Clinical Trials Browser

Phase 1 × OTHER × 3,3'-diindolylmethane × Clear all

NCT01022333 2009-12-01

The Potential for Oral Diindolylmethane (DIM) Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

Phase 1 Unknown

Breast Neoplasms